News

Title
Statement
US Senate Congressional Hearing for Expediting Treatments for Rare, Fatal Diseases
October 2, 2018

IntraBio is pleased to share an exciting media advisory shared by US Senator Rand Paul’s office regarding a US Senate Congressional Hearing that will be by the Children and Families Subcommittee of the Senate Health, Education, Labor, and Pensions Committee on the 3rd of October at 2:30 PM Eastern Time.

The hearing will discuss the future of orphan drug development for rare, fatal, genetic disorders, and features a number of IntraBio’s team as expert witnesses. This is a rare and exciting opportunity to help contribute to the future of orphan drug development, and help ensure novel treatments get to patients with extremely high unmet medical needs. We are very happy to be involved and will continue to make every effort to help improve the lives of patients and families affected by rare diseases.

Hearing Announcement